• Profile
Close

Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma

Journal of Cosmetic Dermatology Jun 23, 2021

Arida DKK, Rebellato PRO, de Campos GLM, et al. - In the present study, the researchers sought to assess the effectiveness of tranexamic acid when applied in the form of drug delivery through microneedling in the treatment of facial melasma. A randomized controlled double-blind split-face trial with 3 monthly sessions in 20 melasma patients: microneedling was conducted in the entire face, and then TA solution was applied to one hemiface and placebo to the other. The authors concluded that tranexamic acid in drug delivery through microneedling provided no additional benefit in the treatment of melisma.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay